vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Smith Douglas Homes Corp. (SDHC). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $260.4M, roughly 1.9× Smith Douglas Homes Corp.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 1.4%, a 5.5% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -9.4%). Over the past eight quarters, Smith Douglas Homes Corp.'s revenue compounded faster (17.3% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
MD vs SDHC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $260.4M |
| Net Profit | $33.7M | $3.5M |
| Gross Margin | — | 19.9% |
| Operating Margin | 9.9% | 6.5% |
| Net Margin | 6.8% | 1.4% |
| Revenue YoY | -1.7% | -9.4% |
| Net Profit YoY | 10.5% | -14.3% |
| EPS (diluted) | $0.40 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $260.4M | ||
| Q3 25 | $492.9M | $262.0M | ||
| Q2 25 | $468.8M | $223.9M | ||
| Q1 25 | $458.4M | $224.7M | ||
| Q4 24 | $502.4M | $287.5M | ||
| Q3 24 | $511.2M | $277.8M | ||
| Q2 24 | $504.3M | $220.9M | ||
| Q1 24 | $495.1M | $189.2M |
| Q4 25 | $33.7M | $3.5M | ||
| Q3 25 | $71.7M | $2.1M | ||
| Q2 25 | $39.3M | $2.4M | ||
| Q1 25 | $20.7M | $2.7M | ||
| Q4 24 | $30.5M | $4.1M | ||
| Q3 24 | $19.4M | $5.3M | ||
| Q2 24 | $-153.0M | $3.6M | ||
| Q1 24 | $4.0M | $3.0M |
| Q4 25 | — | 19.9% | ||
| Q3 25 | — | 21.0% | ||
| Q2 25 | — | 23.2% | ||
| Q1 25 | — | 23.8% | ||
| Q4 24 | — | 25.5% | ||
| Q3 24 | — | 26.5% | ||
| Q2 24 | — | 26.7% | ||
| Q1 24 | — | 26.1% |
| Q4 25 | 9.9% | 6.5% | ||
| Q3 25 | 13.8% | 6.6% | ||
| Q2 25 | 12.8% | 7.7% | ||
| Q1 25 | 7.0% | 8.7% | ||
| Q4 24 | 7.8% | 10.4% | ||
| Q3 24 | 6.6% | 14.2% | ||
| Q2 24 | -31.3% | 11.7% | ||
| Q1 24 | 3.2% | 11.3% |
| Q4 25 | 6.8% | 1.4% | ||
| Q3 25 | 14.5% | 0.8% | ||
| Q2 25 | 8.4% | 1.1% | ||
| Q1 25 | 4.5% | 1.2% | ||
| Q4 24 | 6.1% | 1.4% | ||
| Q3 24 | 3.8% | 1.9% | ||
| Q2 24 | -30.3% | 1.7% | ||
| Q1 24 | 0.8% | 1.6% |
| Q4 25 | $0.40 | $0.39 | ||
| Q3 25 | $0.84 | $0.24 | ||
| Q2 25 | $0.46 | $0.26 | ||
| Q1 25 | $0.24 | $0.30 | ||
| Q4 24 | $0.37 | $0.50 | ||
| Q3 24 | $0.23 | $0.58 | ||
| Q2 24 | $-1.84 | $0.40 | ||
| Q1 24 | $0.05 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $12.7M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $86.7M |
| Total Assets | $2.2B | $557.6M |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $12.7M | ||
| Q3 25 | $340.1M | $14.8M | ||
| Q2 25 | $224.7M | $16.8M | ||
| Q1 25 | $99.0M | $12.7M | ||
| Q4 24 | $229.9M | $22.4M | ||
| Q3 24 | $103.8M | $23.7M | ||
| Q2 24 | $19.4M | $17.3M | ||
| Q1 24 | $8.0M | $32.8M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $86.7M | ||
| Q3 25 | $890.7M | $82.2M | ||
| Q2 25 | $833.8M | $80.0M | ||
| Q1 25 | $789.2M | $76.9M | ||
| Q4 24 | $764.9M | $73.6M | ||
| Q3 24 | $732.5M | $68.4M | ||
| Q2 24 | $706.5M | $62.1M | ||
| Q1 24 | $856.2M | $59.7M |
| Q4 25 | $2.2B | $557.6M | ||
| Q3 25 | $2.2B | $571.6M | ||
| Q2 25 | $2.1B | $570.2M | ||
| Q1 25 | $2.0B | $513.9M | ||
| Q4 24 | $2.2B | $475.9M | ||
| Q3 24 | $2.1B | $460.1M | ||
| Q2 24 | $2.0B | $429.3M | ||
| Q1 24 | $2.2B | $401.3M |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $9.8M |
| Free Cash FlowOCF − Capex | — | $8.7M |
| FCF MarginFCF / Revenue | — | 3.4% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | 3.39× | 2.77× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-36.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $9.8M | ||
| Q3 25 | $137.3M | $22.8M | ||
| Q2 25 | $137.2M | $-28.9M | ||
| Q1 25 | $-117.5M | $-34.9M | ||
| Q4 24 | $133.0M | $5.5M | ||
| Q3 24 | $91.8M | $22.9M | ||
| Q2 24 | $107.0M | $39.0K | ||
| Q1 24 | $-125.2M | $-9.3M |
| Q4 25 | — | $8.7M | ||
| Q3 25 | — | $21.4M | ||
| Q2 25 | — | $-31.1M | ||
| Q1 25 | — | $-35.9M | ||
| Q4 24 | — | $4.8M | ||
| Q3 24 | — | $22.3M | ||
| Q2 24 | — | $-2.1M | ||
| Q1 24 | — | $-9.7M |
| Q4 25 | — | 3.4% | ||
| Q3 25 | — | 8.2% | ||
| Q2 25 | — | -13.9% | ||
| Q1 25 | — | -16.0% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 8.0% | ||
| Q2 24 | — | -1.0% | ||
| Q1 24 | — | -5.1% |
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 0.2% |
| Q4 25 | 3.39× | 2.77× | ||
| Q3 25 | 1.91× | 10.70× | ||
| Q2 25 | 3.49× | -12.24× | ||
| Q1 25 | -5.66× | -13.01× | ||
| Q4 24 | 4.36× | 1.33× | ||
| Q3 24 | 4.72× | 4.28× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | -31.03× | -3.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SDHC
| Southeast | $164.7M | 63% |
| Central | $95.8M | 37% |
